Is your child displaying symptoms of ADHD?

• The study is to treat children with ADHD
• ADHD occurs in 6% to 8% of children worldwide
• The goal of the study medication is to alleviate ADHD symptoms with the primary symptoms being inattention, hyperactivity, and impulsivity.

Study Benefits:

• Study medication is a capsule taken daily and is already approved in children 6 to 12 years old as well as adolescents.
• Has been shown to improve ADHD symptoms in multiple studies.
• There is an option to enroll in a 12-month open label extension (if qualified).
• Close medical care while participating in the trial.

Study Participant Criteria :

• 4 to 5 years of age
• Cannot have been on amphetamines at any time.
• Cannot be on any other ADHD medication during the study.
• Subject must meet criteria for primary diagnosis of ADHD according to the DSM-V

Study Participant Expectations:

• Treatment period of 5 weeks with weekly clinic visits
• Daily oral medication
• Compensation for time and travel

“Did You Know”

• ADHD symptoms affect school performance, extracurricular activities, and home activities.
• ADHD is theorized to result from a deficiency of neurotransmission of dopamine and norepinephrine either through the insufficient sensitivity of the receptors or amount of dopamine produced